The shale oil producer lowered its full-year capital expenditure plan to a range of $5.8 billion to $6.2 billion, a $200 million reduction at the midpoint.
China’s spokesperson said if the U.S. wants to talk, it has to show sincerity and be prepared to correct its wrong practices and cancel the unilateral tariffs.
Organon shares sank 27% Thursday after slashing its dividend by over 90%, triggering analyst downgrades and investor concern. Some retail traders, however, remained upbeat, citing the company’s focus on debt reduction and long-term growth.
Nvidia CEO Jensen Huang warned U.S. lawmakers that export bans on AI chips may unintentionally benefit Huawei, allowing the Chinese tech giant to gain a competitive edge in the global AI race.
TransCode Therapeutics shares surged nearly 39% after reporting promising Phase 1a trial results for its metastatic cancer drug TTX-MC138, with strong retail interest and no major safety concerns.
Wall Street experienced a positive momentum as the S&P 500 marked its eighth consecutive day of gains on Thursday, climbing 0.6% to 5,604.14. This rally helped the index recover from losses incurred due to trade tariffs announced by President Donald Trump.
Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.
Apple CEO Tim Cook warned of a $900 million tariff impact in the June quarter as the company shifts production of iPhones, Macs, and iPads from China to India and Vietnam.
Trump ousts national security adviser Mike Waltz amid internal tensions and a messaging scandal, naming him UN ambassador and replacing him temporarily with Secretary of State Marco Rubio.
Analysts raise ratings for Robinhood (HOOD) after strong Q1 earnings report. Quarterly revenue and EPS beat estimates, but concerns about market changes remain.
